Description
What it is
Dual GLP-1 / glucagon receptor agonist (BI 456906). Investigational for obesity and MASH.
Mechanism
Survodutide engages GLP-1 and glucagon receptors, with proposed effects on hepatic fat reduction alongside body-weight control.
Specifications
- Peptide content: 2mg / vial
- HPLC purity: ≥99.7%
- Form: Lyophilized powder
- Storage: 2–8°C, protected from light
- Shipping: Cold-chain dispatch from EU warehouse, same-day if ordered before 14:00 CET
Certificate of Analysis
Every batch ships with a downloadable Certificate of Analysis showing HPLC purity, mass-spec identity confirmation, and microbial/endotoxin pass results.






Reviews
There are no reviews yet.